Resource Hub


Our podcast

Get tips to empower your learners from conversations with thought leaders in Life Sciences
Listen to the podcasts

Image

Most recent

Allison Hunt | Director, Global Curriculum Lead, Advanced Wound Management, Smith+Nephew

Episode 20: The Personalized Learning Journey with Allison Hunt

Episode, September 28, 2023
Listen onThis episode of the Learning Journey Podcast explores the transformative power of personalized learning in the Life Sciences industry. Joined by education expert Allison Hunt, she discusses how tailored learning experiences can boost learner engagement and performance. Allison delves into the importance of aligning training with business goals, leveraging AI technology for personalized learning, and overcoming barriers to adoption.
Listen now

Our blogs

Read out blog for the latest topics in Life Sciences learning
Read more blogs

Our news

Get the latest news and announcements from ACTO
Read more news
Image

ACTO AI Roleplay Integration with Veeva Vault CRM via X-Pages Now Available for Field Teams to Rehearse Each HCP Conversation Before It Happens

Sales reps and MSLs can launch ACTO CxZone with one click from their planning screens, practice with an HCP avatar grounded in MLR-approved Veeva Vault content, and get immediate feedback to improve their conversation TORONTO and NEW YORK — November 18, 2026 — ACTO, a Veeva Gold Product Partner, today announced that CxZone™, its AI roleplay solution for life sciences
Read More
Responsible AI in Life Sciences Report, by ACTO

Industry Report Shows 64% of Life Sciences Leaders Taking Action to Establish AI Governance

Research points to trust as the real barrier to scaling agentic AI, with 58% saying the industry still lacks clear standards for responsible AI TORONTO and NEW YORK — October 28, 2026 — Life sciences organizations are putting governance in place to scale agentic AI across commercial, medical, and patient-facing work, according to the Responsible AI in Life Sciences (RAIL)
Read More
Image

ACTO Named a Luminary in Everest Group’s “Innovation Watch: Agentic AI in Life Sciences Commercial 2026”

Recognition highlights ACTO’s role-based SuperAgents, cross-platform orchestration, and Life Sciences-focused approach to governed agentic AI TORONTO and NEW YORK–October 5, 2026 — ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced that it has been named a Luminary in Everest Group’s Innovation Watch: Agentic AI in Life Sciences Commercial 2026, a global assessment of leading agentic AI
Read More